1 / 8

Exclusive Research Report On Generic Injectables Market 2022.

According to our new research study on Generic Injectables Market Forecast to 2028 u2013 COVID-19 Impact and Global Analysis u2013 by product type, container type, application, and route of administration,u201d the generic injectables market size is expected to grow from US$ 74.74 billion in 2021 to US$ 150.65 billion by 2028; it is estimated to grow at a CAGR of 10.5% during 2021u20132028. The generic injectables market growth is attributed to low R&D, marketing, and manufacturing costs, and the rising prevalence of chronic illness cases are expected to drive the growth of the market.

nikhilghodse94
Download Presentation

Exclusive Research Report On Generic Injectables Market 2022.

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Generic Injectables Market Global Analysis and Forecast to 2028 Published Date : Mar 2022 Email: sales@theinsightpartners.com

  2. Email: sales@theinsightpartners.com Report Studies  Generic Injectables Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Large Molecule Injectables and Small Molecule Injectables), Container Type (Vials, Premix, Prefilled Syringes, Ampoules, and Others), Application (Oncology, Infectious Diseases, Cardiology, Diabetes, Immunology, and Others), and Route of Administration (Intravenous, Intramuscular, Subcutaneous, and Others), and Geography 2

  3. Email: sales@theinsightpartners.com Generic Injectables Market Overview  The generic injectables market is projected to reach US$ 150.65 billion by 2028 from US$ 74.74 billion in 2021; it is expected to register a CAGR of 10.5% from 2021 to 2028.  Generic injectables are the bioequivalents of their branded counterparts and are not protected by patents. They are safe and effective as the innovator drugs since they have similar active ingredients, dosages, strength, qualities, form, etc. 3

  4. Email: sales@theinsightpartners.com Key Segment Market Segment By Type:-  By Product Type (Large Molecule Injectables and Small Molecule Injectables)  Application (Oncology, Infectious Diseases, Cardiology, Diabetes, Immunology, and Others)  Container Type (Vials, Premix, Prefilled Syringes, Ampoules, and Others) Download Sample Here 4

  5. Email: sales@theinsightpartners.com $50,000 Generic Injectables Market Value $40,000 $30,000 CAGR of $20,000 10.5% $10,000 (2021 - 2028) $0 20XX 20XX 20XX 20XX 20XX Download Sample 5

  6. Email: sales@theinsightpartners.com Company Profiles  Astrazeneca  Baxter International, Inc.  Biocon  Fresenius SE & Co. KGaA  GlaxoSmithKline Plc  Hikma Pharmaceuticals  Johnson & Johnson Services, Inc.  Lupin, Ltd.  Merck & Co., Inc.  Mylan N.V.  Pfizer, Inc Download Sample Here 6

  7. Email: sales@theinsightpartners.com By Geography  North America (the US, Canada, and Mexico)  Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe)  Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific)  Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa)  South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7

  8. THANK YOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com

More Related